Investigating how RNA misregulation affects ALS through the KIF5A gene

RNA Processing Misregulation in KIF5A ALS

NIH-funded research University of California, San Diego · NIH-11033842

This study is looking at how changes in the KIF5A gene might affect the way our cells handle RNA, which could help us understand more about ALS and how it damages motor neurons.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Diego NIH-funded
Lab location1 site (La Jolla, United States)
Project IDNIH-11033842 on NIH RePORTER

What this research studies

This research focuses on understanding the role of the KIF5A gene in Amyotrophic Lateral Sclerosis (ALS), a severe neurodegenerative disease. It explores how mutations in KIF5A, a protein involved in transporting cellular components, lead to changes in RNA processing that may contribute to motor neuron degeneration. By using advanced machine learning techniques and experimental methods, the study aims to uncover the interactions between KIF5A and RNA, particularly in relation to genes associated with ALS. The research will also evaluate how these mutations affect the overall function of RNA-binding proteins and their targets.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Amyotrophic Lateral Sclerosis, particularly those with known mutations in the KIF5A gene.

Not a fit: Patients with ALS who do not have mutations in the KIF5A gene may not benefit directly from this research.

Why it matters

Potential benefit: If successful, this research could lead to new insights into ALS mechanisms and potential therapeutic targets for treatment.

How similar studies have performed: Previous research has shown promising results in understanding ALS through genetic and RNA-related studies, indicating that this approach could yield valuable insights.

Where this research is happening

La Jolla, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndrome
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.